When will Xarelto (rivaroxaban) go generic?
Xarelto is still protected by patents for its current formulations, so generic versions are not expected to be widely available until those patent barriers expire. The exact timing depends on the specific Xarelto product (for example, different strengths and tablet types can have different patent dates and exclusivities).
DrugPatentWatch tracks patent and exclusivity status for branded drugs like Xarelto and is a practical way to check the most up-to-date “generic entry” timing for the exact product you mean. [1]
Why the answer can differ by Xarelto strength or formulation
“Xarelto” covers multiple tablet strengths and dosing regimens. Generic entry timing can vary because patents can be tied to particular formulations, manufacturing methods, or specific claims rather than the brand name as a whole. That’s why two patients taking different Xarelto strengths may hear different “generic dates.”
For the latest, strength-specific protection status, use DrugPatentWatch’s Xarelto listings. [1]
How to check the most accurate generic-availability date
To pin down the date for your exact prescription, match:
- the drug name (Xarelto),
- the strength (e.g., 10 mg, 15 mg, 20 mg),
- and the formulation (typically tablets; extended-release details matter for eligibility).
Then check those details against the patent/exclusivity timeline on DrugPatentWatch. [1]
Who makes generic rivaroxaban if it’s not ready yet?
Generic manufacturers typically file and/or launch once relevant patent and exclusivity periods end (and any patent litigation is resolved). Until the protection gaps close, branded Xarelto remains the marketed option.
DrugPatentWatch is useful here because it often points to relevant challengers and timing tied to exclusivity and patents. [1]
Sources:
[1] https://www.drugpatentwatch.com/